HK1213252A1 - 雙環二氫吡啶酮激酶抑制劑 - Google Patents

雙環二氫吡啶酮激酶抑制劑

Info

Publication number
HK1213252A1
HK1213252A1 HK16101133.8A HK16101133A HK1213252A1 HK 1213252 A1 HK1213252 A1 HK 1213252A1 HK 16101133 A HK16101133 A HK 16101133A HK 1213252 A1 HK1213252 A1 HK 1213252A1
Authority
HK
Hong Kong
Prior art keywords
dihydropyridone
bicyclic
kinase inhibitors
kinase
inhibitors
Prior art date
Application number
HK16101133.8A
Other languages
English (en)
Inventor
Anjali Pandey
Yonghong Song
Qing Xu
Original Assignee
Portola Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Portola Pharm Inc filed Critical Portola Pharm Inc
Publication of HK1213252A1 publication Critical patent/HK1213252A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
HK16101133.8A 2012-09-27 2016-02-01 雙環二氫吡啶酮激酶抑制劑 HK1213252A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261706681P 2012-09-27 2012-09-27
PCT/US2013/000224 WO2014051653A1 (en) 2012-09-27 2013-09-27 Bicyclic dihydropyridone kinase inhibitors

Publications (1)

Publication Number Publication Date
HK1213252A1 true HK1213252A1 (zh) 2016-06-30

Family

ID=50388821

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16101133.8A HK1213252A1 (zh) 2012-09-27 2016-02-01 雙環二氫吡啶酮激酶抑制劑

Country Status (4)

Country Link
US (1) US9533986B2 (zh)
EP (1) EP2900639B1 (zh)
HK (1) HK1213252A1 (zh)
WO (1) WO2014051653A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2900639B1 (en) 2012-09-27 2017-08-16 Portola Pharmaceuticals, Inc. Bicyclic dihydropyridone kinase inhibitors
US11691971B2 (en) 2020-06-19 2023-07-04 Incyte Corporation Naphthyridinone compounds as JAK2 V617F inhibitors
US11753413B2 (en) 2020-06-19 2023-09-12 Incyte Corporation Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors
TW202202498A (zh) * 2020-07-01 2022-01-16 大陸商四川海思科製藥有限公司 一種並環雜環衍生物及其在醫藥上的應用
US11767323B2 (en) 2020-07-02 2023-09-26 Incyte Corporation Tricyclic pyridone compounds as JAK2 V617F inhibitors
US11780840B2 (en) 2020-07-02 2023-10-10 Incyte Corporation Tricyclic urea compounds as JAK2 V617F inhibitors
CN112062770A (zh) * 2020-08-21 2020-12-11 台州学院 一种稠环二氢吡啶酮的制备方法
WO2022046989A1 (en) 2020-08-27 2022-03-03 Incyte Corporation Tricyclic urea compounds as jak2 v617f inhibitors
US11919908B2 (en) 2020-12-21 2024-03-05 Incyte Corporation Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
AR125273A1 (es) 2021-02-25 2023-07-05 Incyte Corp Lactamas espirocíclicas como inhibidores de jak2 v617f
WO2023179567A1 (zh) * 2022-03-22 2023-09-28 上海维申医药有限公司 作为Toll样受体激动剂的嘧啶并哒嗪酮类化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080091948A (ko) * 2007-04-10 2008-10-15 에스케이케미칼주식회사 락탐형 피리딘 화합물을 포함하는 허혈성 질환의 예방 및치료용 약학조성물
AR075854A1 (es) 2009-03-13 2011-05-04 Vitae Pharmaceuticals Inc Inhibidores de beta- secretasa
TW201105669A (en) * 2009-07-30 2011-02-16 Irm Llc Compounds and compositions as Syk kinase inhibitors
CA2779105C (en) 2009-10-29 2016-08-16 Hong Woo Kim Kinase inhibitors
ME02186B (me) 2009-12-23 2016-02-20 Takeda Pharmaceuticals Co Fuzionisani heteroaromatski pirolidinoni kao syk inhibitori
US8846928B2 (en) 2010-11-01 2014-09-30 Portola Pharmaceuticals, Inc. Benzamides and nicotinamides as Syk modulators
AU2011340721A1 (en) 2010-12-07 2013-06-20 Bayer Intellectual Property Gmbh Substituted 1-benzylcycloalkylcarboxlic acids and use thereof
AR084515A1 (es) * 2010-12-22 2013-05-22 Merz Pharma Gmbh & Co Kgaa Derivados heterociclicos nitrogenados, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades asociadas al sistema nervioso central tales como parkinson y alzheimer, entre otras
EP2900639B1 (en) 2012-09-27 2017-08-16 Portola Pharmaceuticals, Inc. Bicyclic dihydropyridone kinase inhibitors

Also Published As

Publication number Publication date
US20150266871A1 (en) 2015-09-24
EP2900639A1 (en) 2015-08-05
US9533986B2 (en) 2017-01-03
EP2900639A4 (en) 2016-04-20
EP2900639B1 (en) 2017-08-16
WO2014051653A1 (en) 2014-04-03

Similar Documents

Publication Publication Date Title
IL265007B (en) Pyrazolopyrimidine compounds as kinase inhibitors
IL261282A (en) Furinone compounds as kinase inhibitors
HK1254429A1 (zh) 絲氨酸/蘇氨酸激酶抑制劑
HK1244004A1 (zh) 内酰胺激酶抑制劑
HK1210775A1 (zh) 作為激酶抑制劑的咪唑並三嗪甲腈
HK1208442A1 (zh) 作為 激酶抑制劑的取代的吡咯並嘧啶基氨基-苯並噻唑酮
HK1215577A1 (zh) 蛋白激酶抑制劑
HK1213252A1 (zh) 雙環二氫吡啶酮激酶抑制劑
PL2634185T3 (pl) Inhibitory kinazy TYK2
HK1211574A1 (zh) 絲氨酸/蘇氨酸激酶抑制劑
HK1209726A1 (zh) 蛋白激酶抑制劑
HK1205506A1 (zh) 炔類化合物的蛋白激酶抑制劑
SG11201500973WA (en) Amino-quinolines as kinase inhibitors
HK1208460A1 (zh) 蛋白激酶抑制劑
HK1213181A1 (zh) 雙環氧雜內酰胺激酶抑制劑

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230923